Abstract:As per the 2022 global tuberculosis (TB) report, TB ranked among the top ten causes of mortality worldwide, surpassing both HIV and malaria in fatalities. It is a communicable disease induced by the Mycobacterium tuberculosis (MTB). Herein the role of molecular modeling tools in the search for new TB therapeutics involves quantitative structure-activity relationship (QSAR), pharmacophore modeling, and molecular docking. In the present work, we compiled approximately 1000 anti-TB candidates from the literature, along with their experimentally determined activities, and classified into three classes based on their biological activities, viz.,pIC, pIC_50, and pMIC_50. All selected compounds were optimized followed by docking them to anti-TB receptors retrieved from the Protein Data Bank. The docking results delineate the nature of interactions between the ligands and their respective receptors, which are prevalently noncovalent, dominated by hydrogen bonds and van der Waals’ interactions. Additionally, DFT-based descriptors were calculated such as constitutional, geometrical, topological, quantum chemical and docking based descriptors basis on their biological activities. The best models were selected on the basis of statistical parameters and were validated by training and test set division.

What problem does this paper attempt to address?

This paper aims to solve the key problems in tuberculosis (TB) treatment, especially the new drug design for drug - resistant tuberculosis. Specifically, the research uses advanced computational techniques, such as Quantitative Structure - Activity Relationship (QSAR), Pharmacophore Modeling and Molecular Docking, to screen and evaluate potential anti - tuberculosis drugs. ### Research Background According to the Global Tuberculosis Report in 2022, tuberculosis is one of the top ten causes of death in the world, and the number of deaths exceeds that of AIDS and malaria. Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (MTB). With the increase of drug - resistant tuberculosis (such as multi - drug - resistant tuberculosis MDR - TB and extensively drug - resistant tuberculosis XDR - TB), traditional treatment regimens are becoming more and more ineffective, so there is an urgent need to develop new anti - tuberculosis drugs. ### Research Methods 1. **Dataset Preparation**: - Approximately 1,000 anti - tuberculosis candidate drugs were collected and classified according to their biological activities (such as pIC50 and pMIC50 values). - Geometric optimization of these compounds was carried out using Density Functional Theory (DFT). 2. **Molecular Docking**: - The GOLD and AutoDock programs were used for molecular docking to determine the interactions between ligands and receptors. - Eleven different anti - tuberculosis receptors (from the Protein Data Bank PDB) were selected, and 30 docking poses were generated for each inhibitor. 3. **QSAR Analysis**: - Multiple descriptors were calculated, including structural, topological, charge, quantum - chemical and docking - related descriptors. - Twelve QSAR models were established through Multiple Linear Regression (MLR) and Partial Least Squares (PLS). ### Main Findings - **Importance of Descriptors**: - Quantum - chemical descriptors play a key role in the models, especially hardness, chemical potential and electrophilicity index. - Molecular docking descriptors (such as binding energy, hydrogen bonds and van der Waals forces) also significantly improve the statistical robustness of the models. - **Model Performance**: - The 12 QSAR models established show good predictive ability on both the training set and the test set. - Especially for the prediction of pIC50 and pMIC50 values, the R² values and cross - validation R² values of the models are both high, indicating that the models have high reliability and accuracy. ### Conclusion This research has successfully screened and evaluated a large number of anti - tuberculosis candidate drugs through the comprehensive use of molecular docking and QSAR analysis. The combination of quantum - chemical descriptors and molecular docking descriptors significantly improves the predictive ability and statistical robustness of the models. These results provide an important theoretical basis and experimental guidance for the development of new anti - tuberculosis drugs. ### Formula Examples - **Calculation of pMIC50 Value**: \[ pMIC50 = -\log(MIC50) \] - **QSAR Model Equation**: \[ Y = D24(-0.11)+D76(-2.05)+D41(151.16)+D8(24.43)+D72(-11.33)+D68(9.37)+D19(-0.42)-176.19 \] Through these methods and techniques, the research provides an important scientific basis for the design and development of anti - tuberculosis drugs.

In-silico studies of anti-tuberculosis drugs using advanced computational techniques

Computational investigation on the anti-tuberculosis potential of novel thiazinane derivatives

Computational Exploration of Isatin Derivatives for InhA Inhibition in Tuberculosis: Molecular Docking, MD Simulations and ADMET Insights

A computational approach to kinome-wide binding affinity profiling of small-molecular inhibitors using dynamic conformations of kinases

An Extensive Computational Investigation of Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors from Diverse‐Lib Compounds Library

Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies

In silico identification of phytochemical inhibitors for multidrug-resistant tuberculosis based on novel pharmacophore generation and molecular dynamics simulation studies

The systematic modeling studies and free energy calculations of the phenazine compounds as anti-tuberculosis agents

Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism

QSAR Modeling, Molecular Docking and ADMET Study of Aryl Fluorosulfate Derivatives as Potential Anti-TB Agents

Synthesis, Biological and Molecular Docking Studies of Thiazole‐Thiadiazole derivatives as potential Anti‐Tuberculosis Agents

Analyzing the role of reducible molecular descriptors and thermodynamic aspects of anti-tuberculosis drugs via QSPR study

Applications of Molecular Simulation in the Discovery of Antituberculosis Drugs: A Review

Structural insights on Mycobacterium tuberculosis thiazole synthase--a molecular dynamics/docking approach

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

Integrated virtual screening and MD simulation study to discover potential inhibitors of mycobacterial electron transfer flavoprotein oxidoreductase

QSPR analysis of distance-based structural indices for drug compounds in tuberculosis treatment

In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis

Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies